The prognostic significance of hematological parameters in women with uterine serous papillary carcinoma (USPC)

被引:12
作者
Younes, Grace [1 ]
Segev, Yakir [1 ]
Begal, Julia [1 ]
Auslender, Ron [1 ]
Goldberg, Yael [1 ]
Amit, Amnon [2 ]
Lavie, Ofer [1 ]
机构
[1] Techn Univ, Rappaport Fac Med, Carmel Med Ctr, Div Gynecol Oncol,Dept Obstet & Gynecol, Haifa, Israel
[2] Techn Univ, Rappaport Fac Med, Rambam Med Ctr, Div Gynecol Oncol,Dept Obstet & Gynecol, Haifa, Israel
关键词
Uterine papillary serous carcinoma; Thrombocytosis; Leukocytosis; Neutrophilia; COLONY-STIMULATING FACTOR; PRETREATMENT SERUM HEMOGLOBIN; PREOPERATIVE LEUKOCYTOSIS; LEUKEMOID REACTION; PLATELET COUNT; THROMBOCYTOSIS; CANCER; CHEMOTHERAPY; SURVIVAL; GRANULOCYTE;
D O I
10.1016/j.ejogrb.2016.01.043
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: Preoperative hematologic parameters: thrombocytosis, leukocytosis and anemia have been demonstrated to be independent poor prognostic factors in ovarian and endometrial cancers. However, little is known about their relation to uterine serous papillary carcinoma (USPC). We evaluated several preoperative hematologic parameters and their association with clinicopathologic features, disease progression and overall survival in USPC patients. Study design: This was a retrospective cohort study reviewing charts of all patients with a histologic pure USPC at two gynecologic oncology centers from January 2000 through July 2012. All patients had comprehensive hematologic tests prior to primary surgical treatment and were exposed to the same adjuvant treatment protocol. Results: The study included 56 patients, mean age at diagnosis 69.4 +/- 15. Six (11%) had platelet count above 400000 10(6)/L, of them four (66%) were dead at the end of follow up (HR = 1.4, p = 0.48; CI 95% 0.5-4.3). The mean hemoglobin level was 12.3 g/dl, fibrinogen 437.5 mg/dL and lymphocytes 2013/mu L. None of these parameters was significantly associated with 5 year survival. Leukocyte and neutrophil levels were adversely associated with survival. Of 15 patients with leukocytosis >10000/mu L, 67% were dead at the end of follow up (HR = 3.98, p = 0.003; CI 95% 1.6-9.8). Of the 27 with neutrophils above 65%, 14(52%) were dead at the end of follow up (HR = 3.1; p = 0.015; CI 95% 1.2-7.8). Conclusions: In patients with USPC, leukocytosis and neutrophilia are associated with aggressive tumor biology, and may predict a lower 5 year survival. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:16 / 20
页数:5
相关论文
共 45 条
  • [21] The prognostic significance of thrombocytosis in uterine papillary serous carcinomas
    Lerner, Dimitry L.
    Walsh, Christine S.
    Cass, Ilana
    Karlan, Beth Y.
    Li, Andrew J.
    [J]. GYNECOLOGIC ONCOLOGY, 2007, 104 (01) : 91 - 94
  • [22] The prognostic significance of thrombocytosis in epithelial ovarian carcinoma
    Li, AJ
    Madden, AC
    Cass, I
    Leuchter, RS
    Lagasse, LD
    Karlan, BY
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 92 (01) : 211 - 214
  • [23] Elevated White Blood Cell Count at the Time of Recurrence Diagnosis Is an Indicator of Short Survival in Patients With Recurrent Cervical Cancer
    Mabuchi, Seiji
    Matsumoto, Yuri
    Hamasaki, Toshimitsu
    Kawano, Mahiru
    Hisamatsu, Takeshi
    Mutch, David G.
    Kimura, Tadashi
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2012, 22 (09) : 1545 - 1551
  • [24] Pretreatment leukocytosis is an indicator of poor prognosis in patients with cervical cancer
    Mabuchi, Seiji
    Matsumoto, Yuri
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Ohashi, Hiroshi
    Morii, Eiichi
    Hamasaki, Toshimitsu
    Aozasa, Katsuyuki
    Mutch, David G.
    Kimura, Tadashi
    [J]. GYNECOLOGIC ONCOLOGY, 2011, 122 (01) : 25 - 32
  • [25] Cancer-related inflammation
    Mantovani, Alberto
    Allavena, Paola
    Sica, Antonio
    Balkwill, Frances
    [J]. NATURE, 2008, 454 (7203) : 436 - 444
  • [26] A leukemoid reaction in a patient with a dedifferentiated liposarcoma
    Nasser, SM
    Choudry, UH
    Nielsen, GP
    Ott, MJ
    [J]. SURGERY, 2001, 129 (06) : 765 - 767
  • [27] Obermair A, 1998, CANCER-AM CANCER SOC, V83, P726, DOI 10.1002/(SICI)1097-0142(19980815)83:4<726::AID-CNCR14>3.0.CO
  • [28] 2-U
  • [29] Obermair A, 2000, ONCOL REP, V7, P639
  • [30] Pandit S, 2012, Med J Malaysia, V67, P542